Synergistic effect of Cinnamomum zeylanicum and Murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats
Abstract Our research work focussed on to evaluating the synergistic action of ethanolic extract and its formulations (F1 and F2) of Cinnamomum zeylanicum (ECZ) and Murraya koenigii (EMK) for antiobesity and anti-hyperlipidemic activity on the high-fat diet on wistar albino rats. In this research wo...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Kumar, Punet [verfasserIn] Singh, Sangam [verfasserIn] Ahmad, Md Iftekhar [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2020 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© Institute of Korean Medicine, Kyung Hee University 2020 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Oriental pharmacy and experimental medicine - Dordrecht : Springer, 2011, 21(2020), 3 vom: 30. Juni, Seite 553-563 |
|---|---|
| Übergeordnetes Werk: |
volume:21 ; year:2020 ; number:3 ; day:30 ; month:06 ; pages:553-563 |
| Links: |
|---|
| DOI / URN: |
10.1007/s13596-020-00460-8 |
|---|
| Katalog-ID: |
SPR044925956 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR044925956 | ||
| 003 | DE-627 | ||
| 005 | 20230519111834.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210827s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s13596-020-00460-8 |2 doi | |
| 035 | |a (DE-627)SPR044925956 | ||
| 035 | |a (SPR)s13596-020-00460-8-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 100 | 1 | |a Kumar, Punet |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Synergistic effect of Cinnamomum zeylanicum and Murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Institute of Korean Medicine, Kyung Hee University 2020 | ||
| 520 | |a Abstract Our research work focussed on to evaluating the synergistic action of ethanolic extract and its formulations (F1 and F2) of Cinnamomum zeylanicum (ECZ) and Murraya koenigii (EMK) for antiobesity and anti-hyperlipidemic activity on the high-fat diet on wistar albino rats. In this research work, rats fed on high-fat diet produced hyperlipidemia (115.00 ± 1.36 mg/dL), which led to an gain in the body weight (215 g), the total cholesterol, triglycerides (166.0 ± 0.577 mg/dL), VLDL (33.20 ± 0.233 mg/dL), total bilirubin (3.280 ± 0.010 mg/dL) and subside the levels of HDL (41.0 ± 0.894 mg/dL) and also changes in albino rats body temperature. ECZ, EMK, and its formulation F1, F2 (200 mg/kg and 400 mg/kg) indicated less in comparison to the HFD induced rats group. The result of the study reflected that ECZ, EMK, and its formulation F1, F2 showed antiobesity and anti-hyperlipidemic action depending on the dose. It was concluded that the ethanolic extract of C. zeylanicum, M. koenigii and its formulation F1, F2 possess antiobesity and anti-hyperlipidemic activity. It is drawn to conclusions, alcoholic extract of C. zeylanicum and M. koenigii and its formulation F1 and F2 possess antiobesity and anti-hyperlipidemic activity. | ||
| 650 | 4 | |a Antiobesity activity |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Antihyperlipidemic activity |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Wistar albino rats |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Synergistic activity |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Singh, Sangam |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmad, Md Iftekhar |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Oriental pharmacy and experimental medicine |d Dordrecht : Springer, 2011 |g 21(2020), 3 vom: 30. Juni, Seite 553-563 |w (DE-627)689127340 |w (DE-600)2655275-9 |x 2211-1069 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2020 |g number:3 |g day:30 |g month:06 |g pages:553-563 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s13596-020-00460-8 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-ASE | ||
| 912 | |a GBV_ILN_120 | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2020 |e 3 |b 30 |c 06 |h 553-563 | ||
| author_variant |
p k pk s s ss m i a mi mia |
|---|---|
| matchkey_str |
article:22111069:2020----::yegsiefcocnaouzyaiuadurykeiifruainoatoeiynhplp |
| hierarchy_sort_str |
2020 |
| publishDate |
2020 |
| allfields |
10.1007/s13596-020-00460-8 doi (DE-627)SPR044925956 (SPR)s13596-020-00460-8-e DE-627 ger DE-627 rakwb eng 610 ASE Kumar, Punet verfasserin aut Synergistic effect of Cinnamomum zeylanicum and Murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Institute of Korean Medicine, Kyung Hee University 2020 Abstract Our research work focussed on to evaluating the synergistic action of ethanolic extract and its formulations (F1 and F2) of Cinnamomum zeylanicum (ECZ) and Murraya koenigii (EMK) for antiobesity and anti-hyperlipidemic activity on the high-fat diet on wistar albino rats. In this research work, rats fed on high-fat diet produced hyperlipidemia (115.00 ± 1.36 mg/dL), which led to an gain in the body weight (215 g), the total cholesterol, triglycerides (166.0 ± 0.577 mg/dL), VLDL (33.20 ± 0.233 mg/dL), total bilirubin (3.280 ± 0.010 mg/dL) and subside the levels of HDL (41.0 ± 0.894 mg/dL) and also changes in albino rats body temperature. ECZ, EMK, and its formulation F1, F2 (200 mg/kg and 400 mg/kg) indicated less in comparison to the HFD induced rats group. The result of the study reflected that ECZ, EMK, and its formulation F1, F2 showed antiobesity and anti-hyperlipidemic action depending on the dose. It was concluded that the ethanolic extract of C. zeylanicum, M. koenigii and its formulation F1, F2 possess antiobesity and anti-hyperlipidemic activity. It is drawn to conclusions, alcoholic extract of C. zeylanicum and M. koenigii and its formulation F1 and F2 possess antiobesity and anti-hyperlipidemic activity. Antiobesity activity (dpeaa)DE-He213 Antihyperlipidemic activity (dpeaa)DE-He213 Wistar albino rats (dpeaa)DE-He213 Synergistic activity (dpeaa)DE-He213 Singh, Sangam verfasserin aut Ahmad, Md Iftekhar verfasserin aut Enthalten in Oriental pharmacy and experimental medicine Dordrecht : Springer, 2011 21(2020), 3 vom: 30. Juni, Seite 553-563 (DE-627)689127340 (DE-600)2655275-9 2211-1069 nnns volume:21 year:2020 number:3 day:30 month:06 pages:553-563 https://dx.doi.org/10.1007/s13596-020-00460-8 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_120 AR 21 2020 3 30 06 553-563 |
| spelling |
10.1007/s13596-020-00460-8 doi (DE-627)SPR044925956 (SPR)s13596-020-00460-8-e DE-627 ger DE-627 rakwb eng 610 ASE Kumar, Punet verfasserin aut Synergistic effect of Cinnamomum zeylanicum and Murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Institute of Korean Medicine, Kyung Hee University 2020 Abstract Our research work focussed on to evaluating the synergistic action of ethanolic extract and its formulations (F1 and F2) of Cinnamomum zeylanicum (ECZ) and Murraya koenigii (EMK) for antiobesity and anti-hyperlipidemic activity on the high-fat diet on wistar albino rats. In this research work, rats fed on high-fat diet produced hyperlipidemia (115.00 ± 1.36 mg/dL), which led to an gain in the body weight (215 g), the total cholesterol, triglycerides (166.0 ± 0.577 mg/dL), VLDL (33.20 ± 0.233 mg/dL), total bilirubin (3.280 ± 0.010 mg/dL) and subside the levels of HDL (41.0 ± 0.894 mg/dL) and also changes in albino rats body temperature. ECZ, EMK, and its formulation F1, F2 (200 mg/kg and 400 mg/kg) indicated less in comparison to the HFD induced rats group. The result of the study reflected that ECZ, EMK, and its formulation F1, F2 showed antiobesity and anti-hyperlipidemic action depending on the dose. It was concluded that the ethanolic extract of C. zeylanicum, M. koenigii and its formulation F1, F2 possess antiobesity and anti-hyperlipidemic activity. It is drawn to conclusions, alcoholic extract of C. zeylanicum and M. koenigii and its formulation F1 and F2 possess antiobesity and anti-hyperlipidemic activity. Antiobesity activity (dpeaa)DE-He213 Antihyperlipidemic activity (dpeaa)DE-He213 Wistar albino rats (dpeaa)DE-He213 Synergistic activity (dpeaa)DE-He213 Singh, Sangam verfasserin aut Ahmad, Md Iftekhar verfasserin aut Enthalten in Oriental pharmacy and experimental medicine Dordrecht : Springer, 2011 21(2020), 3 vom: 30. Juni, Seite 553-563 (DE-627)689127340 (DE-600)2655275-9 2211-1069 nnns volume:21 year:2020 number:3 day:30 month:06 pages:553-563 https://dx.doi.org/10.1007/s13596-020-00460-8 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_120 AR 21 2020 3 30 06 553-563 |
| allfields_unstemmed |
10.1007/s13596-020-00460-8 doi (DE-627)SPR044925956 (SPR)s13596-020-00460-8-e DE-627 ger DE-627 rakwb eng 610 ASE Kumar, Punet verfasserin aut Synergistic effect of Cinnamomum zeylanicum and Murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Institute of Korean Medicine, Kyung Hee University 2020 Abstract Our research work focussed on to evaluating the synergistic action of ethanolic extract and its formulations (F1 and F2) of Cinnamomum zeylanicum (ECZ) and Murraya koenigii (EMK) for antiobesity and anti-hyperlipidemic activity on the high-fat diet on wistar albino rats. In this research work, rats fed on high-fat diet produced hyperlipidemia (115.00 ± 1.36 mg/dL), which led to an gain in the body weight (215 g), the total cholesterol, triglycerides (166.0 ± 0.577 mg/dL), VLDL (33.20 ± 0.233 mg/dL), total bilirubin (3.280 ± 0.010 mg/dL) and subside the levels of HDL (41.0 ± 0.894 mg/dL) and also changes in albino rats body temperature. ECZ, EMK, and its formulation F1, F2 (200 mg/kg and 400 mg/kg) indicated less in comparison to the HFD induced rats group. The result of the study reflected that ECZ, EMK, and its formulation F1, F2 showed antiobesity and anti-hyperlipidemic action depending on the dose. It was concluded that the ethanolic extract of C. zeylanicum, M. koenigii and its formulation F1, F2 possess antiobesity and anti-hyperlipidemic activity. It is drawn to conclusions, alcoholic extract of C. zeylanicum and M. koenigii and its formulation F1 and F2 possess antiobesity and anti-hyperlipidemic activity. Antiobesity activity (dpeaa)DE-He213 Antihyperlipidemic activity (dpeaa)DE-He213 Wistar albino rats (dpeaa)DE-He213 Synergistic activity (dpeaa)DE-He213 Singh, Sangam verfasserin aut Ahmad, Md Iftekhar verfasserin aut Enthalten in Oriental pharmacy and experimental medicine Dordrecht : Springer, 2011 21(2020), 3 vom: 30. Juni, Seite 553-563 (DE-627)689127340 (DE-600)2655275-9 2211-1069 nnns volume:21 year:2020 number:3 day:30 month:06 pages:553-563 https://dx.doi.org/10.1007/s13596-020-00460-8 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_120 AR 21 2020 3 30 06 553-563 |
| allfieldsGer |
10.1007/s13596-020-00460-8 doi (DE-627)SPR044925956 (SPR)s13596-020-00460-8-e DE-627 ger DE-627 rakwb eng 610 ASE Kumar, Punet verfasserin aut Synergistic effect of Cinnamomum zeylanicum and Murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Institute of Korean Medicine, Kyung Hee University 2020 Abstract Our research work focussed on to evaluating the synergistic action of ethanolic extract and its formulations (F1 and F2) of Cinnamomum zeylanicum (ECZ) and Murraya koenigii (EMK) for antiobesity and anti-hyperlipidemic activity on the high-fat diet on wistar albino rats. In this research work, rats fed on high-fat diet produced hyperlipidemia (115.00 ± 1.36 mg/dL), which led to an gain in the body weight (215 g), the total cholesterol, triglycerides (166.0 ± 0.577 mg/dL), VLDL (33.20 ± 0.233 mg/dL), total bilirubin (3.280 ± 0.010 mg/dL) and subside the levels of HDL (41.0 ± 0.894 mg/dL) and also changes in albino rats body temperature. ECZ, EMK, and its formulation F1, F2 (200 mg/kg and 400 mg/kg) indicated less in comparison to the HFD induced rats group. The result of the study reflected that ECZ, EMK, and its formulation F1, F2 showed antiobesity and anti-hyperlipidemic action depending on the dose. It was concluded that the ethanolic extract of C. zeylanicum, M. koenigii and its formulation F1, F2 possess antiobesity and anti-hyperlipidemic activity. It is drawn to conclusions, alcoholic extract of C. zeylanicum and M. koenigii and its formulation F1 and F2 possess antiobesity and anti-hyperlipidemic activity. Antiobesity activity (dpeaa)DE-He213 Antihyperlipidemic activity (dpeaa)DE-He213 Wistar albino rats (dpeaa)DE-He213 Synergistic activity (dpeaa)DE-He213 Singh, Sangam verfasserin aut Ahmad, Md Iftekhar verfasserin aut Enthalten in Oriental pharmacy and experimental medicine Dordrecht : Springer, 2011 21(2020), 3 vom: 30. Juni, Seite 553-563 (DE-627)689127340 (DE-600)2655275-9 2211-1069 nnns volume:21 year:2020 number:3 day:30 month:06 pages:553-563 https://dx.doi.org/10.1007/s13596-020-00460-8 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_120 AR 21 2020 3 30 06 553-563 |
| allfieldsSound |
10.1007/s13596-020-00460-8 doi (DE-627)SPR044925956 (SPR)s13596-020-00460-8-e DE-627 ger DE-627 rakwb eng 610 ASE Kumar, Punet verfasserin aut Synergistic effect of Cinnamomum zeylanicum and Murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats 2020 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Institute of Korean Medicine, Kyung Hee University 2020 Abstract Our research work focussed on to evaluating the synergistic action of ethanolic extract and its formulations (F1 and F2) of Cinnamomum zeylanicum (ECZ) and Murraya koenigii (EMK) for antiobesity and anti-hyperlipidemic activity on the high-fat diet on wistar albino rats. In this research work, rats fed on high-fat diet produced hyperlipidemia (115.00 ± 1.36 mg/dL), which led to an gain in the body weight (215 g), the total cholesterol, triglycerides (166.0 ± 0.577 mg/dL), VLDL (33.20 ± 0.233 mg/dL), total bilirubin (3.280 ± 0.010 mg/dL) and subside the levels of HDL (41.0 ± 0.894 mg/dL) and also changes in albino rats body temperature. ECZ, EMK, and its formulation F1, F2 (200 mg/kg and 400 mg/kg) indicated less in comparison to the HFD induced rats group. The result of the study reflected that ECZ, EMK, and its formulation F1, F2 showed antiobesity and anti-hyperlipidemic action depending on the dose. It was concluded that the ethanolic extract of C. zeylanicum, M. koenigii and its formulation F1, F2 possess antiobesity and anti-hyperlipidemic activity. It is drawn to conclusions, alcoholic extract of C. zeylanicum and M. koenigii and its formulation F1 and F2 possess antiobesity and anti-hyperlipidemic activity. Antiobesity activity (dpeaa)DE-He213 Antihyperlipidemic activity (dpeaa)DE-He213 Wistar albino rats (dpeaa)DE-He213 Synergistic activity (dpeaa)DE-He213 Singh, Sangam verfasserin aut Ahmad, Md Iftekhar verfasserin aut Enthalten in Oriental pharmacy and experimental medicine Dordrecht : Springer, 2011 21(2020), 3 vom: 30. Juni, Seite 553-563 (DE-627)689127340 (DE-600)2655275-9 2211-1069 nnns volume:21 year:2020 number:3 day:30 month:06 pages:553-563 https://dx.doi.org/10.1007/s13596-020-00460-8 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_120 AR 21 2020 3 30 06 553-563 |
| language |
English |
| source |
Enthalten in Oriental pharmacy and experimental medicine 21(2020), 3 vom: 30. Juni, Seite 553-563 volume:21 year:2020 number:3 day:30 month:06 pages:553-563 |
| sourceStr |
Enthalten in Oriental pharmacy and experimental medicine 21(2020), 3 vom: 30. Juni, Seite 553-563 volume:21 year:2020 number:3 day:30 month:06 pages:553-563 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Antiobesity activity Antihyperlipidemic activity Wistar albino rats Synergistic activity |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Oriental pharmacy and experimental medicine |
| authorswithroles_txt_mv |
Kumar, Punet @@aut@@ Singh, Sangam @@aut@@ Ahmad, Md Iftekhar @@aut@@ |
| publishDateDaySort_date |
2020-06-30T00:00:00Z |
| hierarchy_top_id |
689127340 |
| dewey-sort |
3610 |
| id |
SPR044925956 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR044925956</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519111834.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210827s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s13596-020-00460-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR044925956</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s13596-020-00460-8-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kumar, Punet</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Synergistic effect of Cinnamomum zeylanicum and Murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Institute of Korean Medicine, Kyung Hee University 2020</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Our research work focussed on to evaluating the synergistic action of ethanolic extract and its formulations (F1 and F2) of Cinnamomum zeylanicum (ECZ) and Murraya koenigii (EMK) for antiobesity and anti-hyperlipidemic activity on the high-fat diet on wistar albino rats. In this research work, rats fed on high-fat diet produced hyperlipidemia (115.00 ± 1.36 mg/dL), which led to an gain in the body weight (215 g), the total cholesterol, triglycerides (166.0 ± 0.577 mg/dL), VLDL (33.20 ± 0.233 mg/dL), total bilirubin (3.280 ± 0.010 mg/dL) and subside the levels of HDL (41.0 ± 0.894 mg/dL) and also changes in albino rats body temperature. ECZ, EMK, and its formulation F1, F2 (200 mg/kg and 400 mg/kg) indicated less in comparison to the HFD induced rats group. The result of the study reflected that ECZ, EMK, and its formulation F1, F2 showed antiobesity and anti-hyperlipidemic action depending on the dose. It was concluded that the ethanolic extract of C. zeylanicum, M. koenigii and its formulation F1, F2 possess antiobesity and anti-hyperlipidemic activity. It is drawn to conclusions, alcoholic extract of C. zeylanicum and M. koenigii and its formulation F1 and F2 possess antiobesity and anti-hyperlipidemic activity.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiobesity activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antihyperlipidemic activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Wistar albino rats</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Synergistic activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Singh, Sangam</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ahmad, Md Iftekhar</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Oriental pharmacy and experimental medicine</subfield><subfield code="d">Dordrecht : Springer, 2011</subfield><subfield code="g">21(2020), 3 vom: 30. Juni, Seite 553-563</subfield><subfield code="w">(DE-627)689127340</subfield><subfield code="w">(DE-600)2655275-9</subfield><subfield code="x">2211-1069</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:21</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:3</subfield><subfield code="g">day:30</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:553-563</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s13596-020-00460-8</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-ASE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_120</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">21</subfield><subfield code="j">2020</subfield><subfield code="e">3</subfield><subfield code="b">30</subfield><subfield code="c">06</subfield><subfield code="h">553-563</subfield></datafield></record></collection>
|
| author |
Kumar, Punet |
| spellingShingle |
Kumar, Punet ddc 610 misc Antiobesity activity misc Antihyperlipidemic activity misc Wistar albino rats misc Synergistic activity Synergistic effect of Cinnamomum zeylanicum and Murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats |
| authorStr |
Kumar, Punet |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)689127340 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
2211-1069 |
| topic_title |
610 ASE Synergistic effect of Cinnamomum zeylanicum and Murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats Antiobesity activity (dpeaa)DE-He213 Antihyperlipidemic activity (dpeaa)DE-He213 Wistar albino rats (dpeaa)DE-He213 Synergistic activity (dpeaa)DE-He213 |
| topic |
ddc 610 misc Antiobesity activity misc Antihyperlipidemic activity misc Wistar albino rats misc Synergistic activity |
| topic_unstemmed |
ddc 610 misc Antiobesity activity misc Antihyperlipidemic activity misc Wistar albino rats misc Synergistic activity |
| topic_browse |
ddc 610 misc Antiobesity activity misc Antihyperlipidemic activity misc Wistar albino rats misc Synergistic activity |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Oriental pharmacy and experimental medicine |
| hierarchy_parent_id |
689127340 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Oriental pharmacy and experimental medicine |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)689127340 (DE-600)2655275-9 |
| title |
Synergistic effect of Cinnamomum zeylanicum and Murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats |
| ctrlnum |
(DE-627)SPR044925956 (SPR)s13596-020-00460-8-e |
| title_full |
Synergistic effect of Cinnamomum zeylanicum and Murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats |
| author_sort |
Kumar, Punet |
| journal |
Oriental pharmacy and experimental medicine |
| journalStr |
Oriental pharmacy and experimental medicine |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
txt |
| container_start_page |
553 |
| author_browse |
Kumar, Punet Singh, Sangam Ahmad, Md Iftekhar |
| container_volume |
21 |
| class |
610 ASE |
| format_se |
Elektronische Aufsätze |
| author-letter |
Kumar, Punet |
| doi_str_mv |
10.1007/s13596-020-00460-8 |
| dewey-full |
610 |
| author2-role |
verfasserin |
| title_sort |
synergistic effect of cinnamomum zeylanicum and murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats |
| title_auth |
Synergistic effect of Cinnamomum zeylanicum and Murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats |
| abstract |
Abstract Our research work focussed on to evaluating the synergistic action of ethanolic extract and its formulations (F1 and F2) of Cinnamomum zeylanicum (ECZ) and Murraya koenigii (EMK) for antiobesity and anti-hyperlipidemic activity on the high-fat diet on wistar albino rats. In this research work, rats fed on high-fat diet produced hyperlipidemia (115.00 ± 1.36 mg/dL), which led to an gain in the body weight (215 g), the total cholesterol, triglycerides (166.0 ± 0.577 mg/dL), VLDL (33.20 ± 0.233 mg/dL), total bilirubin (3.280 ± 0.010 mg/dL) and subside the levels of HDL (41.0 ± 0.894 mg/dL) and also changes in albino rats body temperature. ECZ, EMK, and its formulation F1, F2 (200 mg/kg and 400 mg/kg) indicated less in comparison to the HFD induced rats group. The result of the study reflected that ECZ, EMK, and its formulation F1, F2 showed antiobesity and anti-hyperlipidemic action depending on the dose. It was concluded that the ethanolic extract of C. zeylanicum, M. koenigii and its formulation F1, F2 possess antiobesity and anti-hyperlipidemic activity. It is drawn to conclusions, alcoholic extract of C. zeylanicum and M. koenigii and its formulation F1 and F2 possess antiobesity and anti-hyperlipidemic activity. © Institute of Korean Medicine, Kyung Hee University 2020 |
| abstractGer |
Abstract Our research work focussed on to evaluating the synergistic action of ethanolic extract and its formulations (F1 and F2) of Cinnamomum zeylanicum (ECZ) and Murraya koenigii (EMK) for antiobesity and anti-hyperlipidemic activity on the high-fat diet on wistar albino rats. In this research work, rats fed on high-fat diet produced hyperlipidemia (115.00 ± 1.36 mg/dL), which led to an gain in the body weight (215 g), the total cholesterol, triglycerides (166.0 ± 0.577 mg/dL), VLDL (33.20 ± 0.233 mg/dL), total bilirubin (3.280 ± 0.010 mg/dL) and subside the levels of HDL (41.0 ± 0.894 mg/dL) and also changes in albino rats body temperature. ECZ, EMK, and its formulation F1, F2 (200 mg/kg and 400 mg/kg) indicated less in comparison to the HFD induced rats group. The result of the study reflected that ECZ, EMK, and its formulation F1, F2 showed antiobesity and anti-hyperlipidemic action depending on the dose. It was concluded that the ethanolic extract of C. zeylanicum, M. koenigii and its formulation F1, F2 possess antiobesity and anti-hyperlipidemic activity. It is drawn to conclusions, alcoholic extract of C. zeylanicum and M. koenigii and its formulation F1 and F2 possess antiobesity and anti-hyperlipidemic activity. © Institute of Korean Medicine, Kyung Hee University 2020 |
| abstract_unstemmed |
Abstract Our research work focussed on to evaluating the synergistic action of ethanolic extract and its formulations (F1 and F2) of Cinnamomum zeylanicum (ECZ) and Murraya koenigii (EMK) for antiobesity and anti-hyperlipidemic activity on the high-fat diet on wistar albino rats. In this research work, rats fed on high-fat diet produced hyperlipidemia (115.00 ± 1.36 mg/dL), which led to an gain in the body weight (215 g), the total cholesterol, triglycerides (166.0 ± 0.577 mg/dL), VLDL (33.20 ± 0.233 mg/dL), total bilirubin (3.280 ± 0.010 mg/dL) and subside the levels of HDL (41.0 ± 0.894 mg/dL) and also changes in albino rats body temperature. ECZ, EMK, and its formulation F1, F2 (200 mg/kg and 400 mg/kg) indicated less in comparison to the HFD induced rats group. The result of the study reflected that ECZ, EMK, and its formulation F1, F2 showed antiobesity and anti-hyperlipidemic action depending on the dose. It was concluded that the ethanolic extract of C. zeylanicum, M. koenigii and its formulation F1, F2 possess antiobesity and anti-hyperlipidemic activity. It is drawn to conclusions, alcoholic extract of C. zeylanicum and M. koenigii and its formulation F1 and F2 possess antiobesity and anti-hyperlipidemic activity. © Institute of Korean Medicine, Kyung Hee University 2020 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_120 |
| container_issue |
3 |
| title_short |
Synergistic effect of Cinnamomum zeylanicum and Murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats |
| url |
https://dx.doi.org/10.1007/s13596-020-00460-8 |
| remote_bool |
true |
| author2 |
Singh, Sangam Ahmad, Md Iftekhar |
| author2Str |
Singh, Sangam Ahmad, Md Iftekhar |
| ppnlink |
689127340 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s13596-020-00460-8 |
| up_date |
2024-07-04T02:50:09.393Z |
| _version_ |
1803615112416722944 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR044925956</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519111834.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210827s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s13596-020-00460-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR044925956</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s13596-020-00460-8-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kumar, Punet</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Synergistic effect of Cinnamomum zeylanicum and Murraya koenigii formulation for antiobesity and hypolipidemic activity on wistar albino rats</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Institute of Korean Medicine, Kyung Hee University 2020</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Our research work focussed on to evaluating the synergistic action of ethanolic extract and its formulations (F1 and F2) of Cinnamomum zeylanicum (ECZ) and Murraya koenigii (EMK) for antiobesity and anti-hyperlipidemic activity on the high-fat diet on wistar albino rats. In this research work, rats fed on high-fat diet produced hyperlipidemia (115.00 ± 1.36 mg/dL), which led to an gain in the body weight (215 g), the total cholesterol, triglycerides (166.0 ± 0.577 mg/dL), VLDL (33.20 ± 0.233 mg/dL), total bilirubin (3.280 ± 0.010 mg/dL) and subside the levels of HDL (41.0 ± 0.894 mg/dL) and also changes in albino rats body temperature. ECZ, EMK, and its formulation F1, F2 (200 mg/kg and 400 mg/kg) indicated less in comparison to the HFD induced rats group. The result of the study reflected that ECZ, EMK, and its formulation F1, F2 showed antiobesity and anti-hyperlipidemic action depending on the dose. It was concluded that the ethanolic extract of C. zeylanicum, M. koenigii and its formulation F1, F2 possess antiobesity and anti-hyperlipidemic activity. It is drawn to conclusions, alcoholic extract of C. zeylanicum and M. koenigii and its formulation F1 and F2 possess antiobesity and anti-hyperlipidemic activity.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antiobesity activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antihyperlipidemic activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Wistar albino rats</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Synergistic activity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Singh, Sangam</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ahmad, Md Iftekhar</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Oriental pharmacy and experimental medicine</subfield><subfield code="d">Dordrecht : Springer, 2011</subfield><subfield code="g">21(2020), 3 vom: 30. Juni, Seite 553-563</subfield><subfield code="w">(DE-627)689127340</subfield><subfield code="w">(DE-600)2655275-9</subfield><subfield code="x">2211-1069</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:21</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:3</subfield><subfield code="g">day:30</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:553-563</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s13596-020-00460-8</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-ASE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_120</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">21</subfield><subfield code="j">2020</subfield><subfield code="e">3</subfield><subfield code="b">30</subfield><subfield code="c">06</subfield><subfield code="h">553-563</subfield></datafield></record></collection>
|
| score |
7.400055 |